Search clinical trials for: aspirin, clopidogrel, cilostazol

Total 1898 results

Yonsei University

Unknown

Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)

Critical Limb Ischemia

Korea, Republic of
Shenyang Northern Hospital

Completed

Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation

Percutaneous Coronary Intervention | Acute Coronary Syndromes | Clopidogrel Low Responsiveness

China
Samsung Medical Center

Completed

The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol (4C-DES)

Clopidogrel Non-Responsiveness

Korea, Republic of
Seoul National University Hospital
CKD Pharmaceutical Limited

Completed

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Coronary Heart Disease
Chinese Academy of Medical Sciences, Fuwai Hospital
Zhejiang Otsuka Pharmaceutical Co., Ltd.; Haemonetics Corporation; Beijing Municipal...

Completed

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients (CREATIVE)

Coronary Heart Disease

China
Gyeongsang National University Hospital

Unknown

Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism (ACCEL2C19)

Coronary Artery Stenosis | Maximal Platelet Aggregation | Late Platelet Aggregation | High Post-Treatment Platelet Reactivity

Korea, Republic of
Seoul National University Hospital

Completed

The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers

Healthy

Korea, Republic of
Gyeongsang National University Hospital

Completed

Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism (ACCELAMI2C19)

Myocardial Infarction

Korea, Republic of
St. Antonius Hospital

Completed

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (POPular-TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Disease

Netherlands, Belgium, Czechia, Luxembourg
Shenyang Northern Hospital

Completed

Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

Ischemic Heart Disease | Acute Coronary Syndromes

China
Chong Kun Dang Pharmaceutical
Inje University

Completed

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial

Coronary Artery Disease

Korea, Republic of
Centre Hospitalier de PAU

Terminated

Anticoagulant Treatments and Percutaneous Coronary Angioplasty (TACA)

Coronary Artery Disease

France
Second Affiliated Hospital, School of Medicine,...

Recruiting

Antiplatelet Therapy for AIS Patients With Thrombocytopenia (PERSIST)

Thrombocytopenia | Acute Ischemic Stroke

China
Japan Cardiovascular Research Foundation
Otsuka Pharmaceutical Co., Ltd.

Completed

Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS・com)

Noncardioembolic Cerebral Infarction

Japan
Shenyang Northern Hospital
Changhai Hospital; ANKON medical technologies (Shanghai)Co.,LTD

Completed

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation (OPT-PEACE)

Ischemic Heart Disease | Gastrointestinal Injury

China
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE) (DES-LATE)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Association of Clopidogrel Therapy and Stent Thrombosis (REAL-LATE)

Coronary Artery Disease

Korea, Republic of
Codman & Shurtleff

Terminated

VISSIT Intracranial Stent Study for Ischemic Therapy (VISSIT)

Ischemic Stroke | Transient Ischemic Attack
Juan J Badimon
AstraZeneca

Completed

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Coronary Artery Disease | Type-2 Diabetes Mellitus

United States
Catholic University of the Sacred Heart

Unknown

Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events

Cardiovascular Disease | Polyvascular Disease

Italy
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation (ZEST-LATE)

Coronary Artery Disease

Korea, Republic of
Gyeongsang National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Unknown

Cilostazol and Endothelial Progenitor Cell (EPISODE)

Myocardial Infarction, Acute
Seoul National University Hospital
Hanmi Pharmaceutical co., ltd.

Completed

Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting

Coronary Artery Disease

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
Fédération Française de Cardiologie

Completed

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation (OPTIDUAL)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis

France
Hamilton Health Sciences Corporation

Completed

Warfarin After Anterior ST-Elevation Myocardial Infarction

Myocardial Infarction

Canada
The 476th Hospital of People's Liberation Army

Unknown

Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis

Intracranial Atherosclerosis
Chong Kun Dang Pharmaceutical
Inje University

Completed

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination

Coronary Artery Disease

Korea, Republic of
University of Athens

Completed

A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI (PTOLEMAIOS)

Aortic Valve Stenosis

Greece
Andres Iñiguez Romo, MD, PhD

Completed

Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI (AUREA)

Stroke | Aortic Valve Stenosis

Spain
Jeil Pharmaceutical Co., Ltd.

Completed

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent

ANEURYSM CORONARY ARTERY
Kyunghee University Medical Center

Completed

Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease (CKD)

Chronic Kidney Disease | Stable Angina

Korea, Republic of
The Cleveland Clinic

Terminated

Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.

Aortic Valve Disorder

United States
Seoul National University Hospital

Completed

Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin

DRUG REACTIONS

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation (GUIDE-BVS)

Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Active, not recruiting

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS LATE)

Coronary Disease | Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Inova Health Care Services
Merck Sharp & Dohme LLC

Completed

Vorapaxar on Thrombin Generation and Coagulability

Myocardial Infarction | Coronary Artery Disease | Peripheral Vascular Disease

United States
Inje University

Completed

The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers

Interaction
Peking Union Medical College Hospital

Completed

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China (SMART)

Stroke

China
CeloNova BioSciences, Inc.
ClinLogix. LLC

Terminated

COBRA SHIELD OCT Study

Stable Angina

Finland
Sichuan Provincial People's Hospital

Recruiting

Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis (PATH-ICAS)

Ischemic Stroke | Intracranial Arteriosclerosis | Secondary Prevention | Antiplatelet Drug

China
Seoul National University Bundang Hospital
Seoul St. Mary's Hospital; Asan Medical Center; Seoul National University Hospital and other collaborators

Recruiting

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Endovascular Procedures | Aneurysm Cerebral

Korea, Republic of
University of Massachusetts, Worcester
Bristol-Myers Squibb; Sanofi

Completed

PACT (Platelet Activity After Clopidogrel Termination) (PACT)

Clopidogrel | Blood Platelets

United States
China National Center for Cardiovascular Diseases

Unknown

The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease

Atherosclerosis

China
Baim Institute for Clinical Research
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Boston Scientific... and other collaborators

Completed

The Dual Antiplatelet Therapy Study (DAPT Study)

Coronary Artery Disease

United States, Australia, Czechia, New Zealand, United Kingdom, Germany, Hungary, Poland, France, Romania
Beijing Tiantan Hospital

Unknown

Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling (ATIASC)

Embolic Stroke

China
Cordis Corporation

Unknown

CYPRESS - CYPHER for Evaluating Sustained Safety

Coronary Artery Disease

United States
Kafrelsheikh University

Recruiting

Clopidogrel Versus Cilostazol in Ischemic Stroke

Ischemic Stroke

Egypt
Anhui Medical University

Recruiting

Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study

Cognitive Impairment | Intracranial Atherosclerosis | Cerebrovascular Event

China
Cogentus Pharmaceuticals

Terminated

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) (COGENT-1)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

United States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine
Ruhr University of Bochum

Completed

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan) (BOCLAplan)

Coronary Artery Disease

Germany

Search clinical trials for: aspirin, clopidogrel, cilostazol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations